Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments
Site Search
Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments
CFF-Championed Bill Eliminates Barriers to Participation in Clinical Trials for People with CF and other Rare Diseases
Legislation Includes Measures to Increase Patient and Expert Participation in FDA Review of Rare Disease Drugs
Las personas con fibrosis quística y sus familias se han enfrentado a importantes cargas económicas debido a los programas acumuladores de copago. Familiarícese con estos programas y lo que implican para usted y sus seres queridos.
People with cystic fibrosis and their families have faced significant cost burdens due to copay accumulator programs. Get caught up on these programs and what they mean for you and your loved ones.